SEDANA Sedana Medical AB (publ)
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the connector on the agent line of the Sedaconda ACD and Sedana Medical filling adapters; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance of sedation in intubated or tracheostomised mechanically ventilated adult and paediatric patients from 3 years of age; Sedaconda Filling Adapter, a single-use medical device; FlurAbsorb Pro-L and Pro-S; FlurAbsorb and Mounts; Scavenging Tube, a one piece pre-connected tube, that is designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; and Mindray exhaust connector enables to connect the exhaust of the ventilator to an active or passive scavenging system. The company was founded in 1999 and is headquartered in Danderyd, Sweden.…
Industry Peers
Medical DevicesKey Statistics
About Sedana Medical (STO: SEDANA)
›
Sedana Medical (STO: SEDANA) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 116 employees.
The shares were at 8.950 SEK on 19 November 2026, down 7.5% over 52 weeks. Its 52-week range is 7.900 SEK to 13.92 SEK: the price is 35.7% below the high and 13.3% above the low.
Its market capitalisation is 889.07M SEK.
Sedana Medical reports return on equity of -6.6%, an operating margin of -18.0% and revenue up 7.2% year over year.
It holds more cash than debt, a net cash position of 33.46M SEK. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 17.00 SEK is 89.9% above the current price. The next earnings report is expected on 11 February 2027.